BACKGROUND: Cardiovascular disease is increased among HIV-infected patients, but little is known regarding ischemic stroke rates. We sought to compare stroke rates and determine stroke risk factors in HIV-infected versus non-HIV-infected patients. METHODS: An HIV cohort and matched non-HIV comparator cohort seen between 1996 and 2009 were identified from a Boston health care system. The primary endpoint was ischemic stroke, defined using International Classification of Diseases (ICD) codes. Unadjusted stroke incidence rates were calculated. Cox proportional hazards modeling was used to determine adjusted hazard ratios (HRs). RESULTS: The incidence rate of ischemic stroke was 5.27 per 1000 person-years in HIV-infected compared with 3.75 in non-HIV-infected patients, with an unadjusted HR of 1.40 [95% confidence interval (CI): 1.17 to 1.69, P < 0.001]. HIV remained an independent predictor of stroke after controlling for demographics and stroke risk factors (HR: 1.21, 95% CI: 1.01 to 1.46, P = 0.043). The relative increase in stroke rates (HIV vs. non-HIV) was significantly higher in younger HIV patients (incidence rate ratio: 4.42, 95% CI: 1.56 to 11.09, age 18-29; 2.96, 1.69-4.96, age: 30-39; 1.53, 1.06-2.17, age: 40-49), and in women [HR: 2.16 (95% CI: 1.53 to 3.04) for women vs. HR: 1.18 (95% CI: 0.95 to 1.47) for men]. Among HIV patients, increased HIV RNA (HR: 1.10, 95% CI: 1.04 to 1.17, P = 0.001) was associated with an increased risk of stroke. CONCLUSIONS: Stroke rates were increased among HIV-infected patients, independent of common stroke risk factors, particularly among young patients and women.
BACKGROUND:Cardiovascular disease is increased among HIV-infectedpatients, but little is known regarding ischemic stroke rates. We sought to compare stroke rates and determine stroke risk factors in HIV-infected versus non-HIV-infectedpatients. METHODS: An HIV cohort and matched non-HIV comparator cohort seen between 1996 and 2009 were identified from a Boston health care system. The primary endpoint was ischemic stroke, defined using International Classification of Diseases (ICD) codes. Unadjusted stroke incidence rates were calculated. Cox proportional hazards modeling was used to determine adjusted hazard ratios (HRs). RESULTS: The incidence rate of ischemic stroke was 5.27 per 1000 person-years in HIV-infected compared with 3.75 in non-HIV-infectedpatients, with an unadjusted HR of 1.40 [95% confidence interval (CI): 1.17 to 1.69, P < 0.001]. HIV remained an independent predictor of stroke after controlling for demographics and stroke risk factors (HR: 1.21, 95% CI: 1.01 to 1.46, P = 0.043). The relative increase in stroke rates (HIV vs. non-HIV) was significantly higher in younger HIVpatients (incidence rate ratio: 4.42, 95% CI: 1.56 to 11.09, age 18-29; 2.96, 1.69-4.96, age: 30-39; 1.53, 1.06-2.17, age: 40-49), and in women [HR: 2.16 (95% CI: 1.53 to 3.04) for women vs. HR: 1.18 (95% CI: 0.95 to 1.47) for men]. Among HIVpatients, increased HIV RNA (HR: 1.10, 95% CI: 1.04 to 1.17, P = 0.001) was associated with an increased risk of stroke. CONCLUSIONS:Stroke rates were increased among HIV-infectedpatients, independent of common stroke risk factors, particularly among young patients and women.
Authors: Raphael Carandang; Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; William B Kannel; Philip A Wolf Journal: JAMA Date: 2006-12-27 Impact factor: 56.272
Authors: Virginia A Triant; Susan Regan; Hang Lee; Paul E Sax; James B Meigs; Steven K Grinspoon Journal: J Acquir Immune Defic Syndr Date: 2010-12-15 Impact factor: 3.731
Authors: Anthony Solages; Joseph A Vita; David J Thornton; Jessica Murray; Timothy Heeren; Donald E Craven; C Robert Horsburgh Journal: Clin Infect Dis Date: 2006-03-31 Impact factor: 9.079
Authors: Robert C Kaplan; Lawrence A Kingsley; Stephen J Gange; Lorie Benning; Lisa P Jacobson; Jason Lazar; Kathryn Anastos; Phyllis C Tien; A Richey Sharrett; Howard N Hodis Journal: AIDS Date: 2008-08-20 Impact factor: 4.177
Authors: Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren Journal: N Engl J Med Date: 2007-04-26 Impact factor: 91.245
Authors: Alexandra Mangili; Denise L Jacobson; Jul Gerrior; Joseph F Polak; Sherwood L Gorbach; Christine A Wanke Journal: Clin Infect Dis Date: 2007-04-05 Impact factor: 9.079
Authors: W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport Journal: N Engl J Med Date: 2006-11-30 Impact factor: 91.245
Authors: Caroline A Sabin; Signe W Worm; Rainer Weber; Peter Reiss; Wafaa El-Sadr; Francois Dabis; Stephane De Wit; Matthew Law; Antonella D'Arminio Monforte; Nina Friis-Møller; Ole Kirk; Christian Pradier; Ian Weller; Andrew N Phillips; Jens D Lundgren Journal: Lancet Date: 2008-04-02 Impact factor: 202.731
Authors: Kiran T Thakur; Jennifer L Lyons; Bryan R Smith; Russell T Shinohara; Farrah J Mateen Journal: J Neurovirol Date: 2015-07-09 Impact factor: 2.643
Authors: Markella V Zanni; Kathleen V Fitch; Meghan Feldpausch; Allison Han; Hang Lee; Michael T Lu; Suhny Abbara; Heather Ribaudo; Pamela S Douglas; Udo Hoffmann; Janet Lo; Steven K Grinspoon Journal: AIDS Date: 2014-09-10 Impact factor: 4.177
Authors: Homer L Twigg; Ronald Crystal; Judith Currier; Paul Ridker; Nancy Berliner; Hans-Peter Kiem; George Rutherford; Shimian Zou; Simone Glynn; Renee Wong; Emmanuel Peprah; Michael Engelgau; Tony Creazzo; Sandra Colombini-Hatch; Elisabet Caler Journal: AIDS Res Hum Retroviruses Date: 2017-06-26 Impact factor: 2.205
Authors: Farrah J Mateen; Wendy S Post; Ned Sacktor; Alison G Abraham; James T Becker; Bryan R Smith; Roger Detels; Eileen Martin; John P Phair; Russell T Shinohara Journal: Neurology Date: 2013-11-08 Impact factor: 9.910